Method and corresponding kit for administering an adductor canal block

ABSTRACT

Apparatus for administering certain nerve blocks includes a sheath constructed from a flexible ultrasound echogenic material, a more rigid introducer/dilator for introducing the sheath into the patient, and an ultrasound echogenic catheter for inserting through the sheath once the distal end of the sheath is in place adjacent the nerve(s) to be blocked and the introducer/dilator has been withdrawn. The catheter has provisions at its proximal end for connecting to a source of local anesthetic. Methods for use of this apparatus are also described.

RELATED APPLICATIONS

This application is a divisional of U.S. patent application Ser. No.13/359,445, filed on Jan. 26, 2012, which claims benefit under 35 U.S.C.§119(e) to: U.S. Ser. No. 61/436,260, filed Jan. 26, 2011; U.S. Ser. No.61/472,264 filed Apr. 6, 2011; U.S. Ser. No. 61/478,640 filed Apr. 25,2011; and, U.S. Ser. No. 61/506,391 filed Jul. 11, 2011. The disclosuresof: U.S. Ser. No. 61/436,260; U.S. Ser. No. 61/472,264; U.S. Ser. No.61/478,640; and, U.S. Ser. No. 61/506,391 are hereby incorporated hereinby reference.

The invention relates to methods and apparatus for administeringpercutaneous nerve blocks including, for example: laparoscopictransversus abdominis plane (hereinafter sometimes LAP TAP) blocks; openTAP blocks; fascia iliaca blocks (hereinafter sometimes FIBs);paravertebral blocks; femoral nerve blocks; brachial plexus nerveblocks; sciatic nerve blocks; saphenous nerve blocks; and the like.

According to an aspect, a method for administering a transversusabdominis plane (TAP) block to a patient comprises: distending thepatient's abdomen; while the patient's abdomen is distended, penetratingthe exterior wall of the abdomen with a needle sheathed within a sheathhaving an open distal end through which a distal end of the needleprojects; advancing the sheathed needle to the belly of the transversusabdominis rectus muscle (TAR); administering an amount of a localanesthetic; viewing the peritoneum for a bulge adjacent the locationwhere the local anesthetic is being administered; removing the needlefrom the sheath; inserting a catheter through the sheath until thecatheter extends from a distal end of the sheath; removing the sheath;connecting a proximal end of the catheter to a source of localanesthetic; and, commencing anesthesia.

Illustratively according to this aspect, viewing the peritoneum for abulge adjacent the location where the local anesthetic is beingadministered comprises viewing the peritoneum using (a) laparoscopiccamera(s) and monitor(s).

Illustratively according to this aspect, advancing the sheathed needleto the belly of the TAR comprises penetrating the patient's skin, fat,external oblique muscle, internal oblique muscle, and TAR, and slidingthe sheathed needle in a plane parallel to and just outside thepatient's peritoneum.

Illustratively according to this aspect, connecting a proximal end ofthe catheter to a source of local anesthetic comprises attaching anadapter to an external end of the catheter and attaching the adapter toan infusion pump.

According to another aspect, a method for administering a paravertebralblock (PVB) to a patient comprises: marking at least some of thepatient's cervical (C) and thoracic (T) spinous processes; determiningthe depth of the patient's transverse process and external intercostalmuscle at each C and/or T level to be blocked; administering localanesthetic at the T5 level; introducing a first needle sheathed within afirst sheath having an open distal end through which a distal end of thefirst needle projects at the T5 level, approximately 1.25-2.54 cmlateral from the patient's T5 spinous process under the skin to a depthjust above the patient's external intercostal muscle; advancing thesheathed first needle cephalad, at a depth just above the externalintercostal muscle of each vertebra, maintaining substantially constantlateral distance of approximately 1.25-2.54 cm from the patient'sspinous process; halting advancement of the sheathed first needle whenthe highest level marked C spinous process is reached; withdrawing thefirst needle from the first sheath; advancing a first catheter into thefirst sheath; removing the first sheath while leaving the first catheterin place; connecting a proximal end of the first catheter to a source oflocal anesthetic; and, commencing anesthesia.

Illustratively according to this aspect, the method is administered tothe patient with the patient in the prone position.

Illustratively according to this aspect, the method is administered tothe patient with the patient in the lateral decubitus position.

Illustratively according to this aspect, marking at least some of thepatient's cervical (C) and thoracic (T) spinous processes comprisesmarking the patient's C7 to T5 spinous processes.

Illustratively according to this aspect, advancing the sheathed firstneedle cephalad is performed under ultrasound guidance.

Illustratively according to this aspect, advancing the sheathed firstneedle cephalad is aided with intermittent injection of localanesthetic.

Illustratively according to this aspect, connecting a proximal end ofthe first catheter to a source of local anesthetic comprises attachingan adapter to an external end of the first catheter and attaching theadapter to an infusion pump.

Further illustratively according to this aspect, the method comprises:introducing a second needle sheathed within a second sheath having anopen distal end through which a distal end of the second needle projectsat the T5 level, approximately 1.25-2.54 cm lateral from the patient'sT5 spinous process under the skin to a depth just above the patient'sexternal intercostal muscle; advancing the sheathed second needlecaudad, at a depth just above the external intercostal muscle of eachvertebra, maintaining substantially constant lateral distance from thepatient's spinous process of approximately 1.25-2.54 cm; haltingadvancement of the sheathed second needle when the lowest level marked Tspinous process is reached; withdrawing the second needle from thesecond sheath; advancing a second catheter into the second sheath;removing the second sheath while leaving the second catheter in place;connecting a proximal end of the second catheter to a source of localanesthetic; and, commencing anesthesia.

Further illustratively according to this aspect, the method comprises:introducing a second needle sheathed within a second sheath having anopen distal end through which a distal end of the second needle projectsat the T5 level on the opposite lateral side of the patient's spine fromthe first sheathed needle, approximately 1.25-2.54 cm lateral from thepatient's T5 spinous process under the skin to a depth just above thepatient's external intercostal muscle; advancing the sheathed secondneedle cephalad, at a depth just above the external intercostal muscleof each vertebra, maintaining substantially constant lateral distancefrom the patient's spinous process of approximately 1.25-2.54 cm;halting advancement of the sheathed second needle when the highest levelmarked C spinous process is reached; withdrawing the second needle fromthe second sheath; advancing a second catheter into the second sheath;removing the second sheath while leaving the second catheter in place;connecting a proximal end of the second catheter to a source of localanesthetic; and, commencing anesthesia.

According to another aspect, a method for administering an adductorcanal block (ACB) to a patient comprises: identifying the patient'ssartorius muscle; advancing a needle sheathed within a sheath having anopen distal end through which a distal end of the needle projects to thebase of the sartorius muscle; injecting a few milliters of a localanesthetic to identify the bottom of the sartorius fascia; advancing thesheathed needle through the sartorius fascia; administering anadditional approximately 30 milliters of a local anesthetic; removingthe needle, leaving the sheath in the patient's adductor canal;inserting a catheter into the sheath and advancing a distal end of thecatheter through the sheath to the adductor canal; removing the sheath;connecting a proximal end of the catheter to a source of localanesthetic; and, commencing anesthesia.

Illustratively according to this aspect, identifying the patient'ssartorius muscle comprises identifying the patient's sartorius muscleusing ultrasound.

Illustratively according to this aspect, connecting a proximal end ofthe catheter to a source of local anesthetic and commencing anesthesiacomprise connecting a proximal end of the catheter to a constantinfusion pump to deliver the local anesthetic postoperatively at aninitial flow rate of about 6 ml/hour and at a rate of about 2-4 ml/hrper day one day postoperative.

According to another aspect, a method for administering a peripheralnerve block to a patient comprises: penetrating the body of the patientwith a first needle sheathed within a first sheath having an open distalend through which a distal end of the first needle projects; the firstneedle being treated to render its surface electrically non-conductiveexcept adjacent its distal end; advancing the sheathed first needle tothe general location of the nerve to be blocked; passing a currentthrough the first needle and the patient's body to stimulate nerves inthe area of the distal end of the first needle; observing the effect ofsuch stimulation; repeating until the distal end of the first needle isat the location of the peripheral nerve to be blocked; administeringlocal anesthetic through the first needle; withdrawing the first needle;inserting a first catheter through the first sheath; connecting aproximal end of the first catheter to a source of local anesthetic; and,commencing anesthesia via the first catheter.

Further illustratively according to this aspect, the method comprises:introducing a second needle sheathed within a second sheath having anopen distal end through which a distal end of the second needle projectsinto the body of the patient in a direction other than the direction inwhich the sheathed first needle was directed; advancing the sheathedsecond needle to the general location of the distal end of the firstcatheter; withdrawing the second needle; inserting a second catheterthrough the second sheath; advancing the second catheter past the distalend of the first sheath; removing the first sheath; removing the secondsheath; connecting a proximal end of the second catheter to a source oflocal anesthetic; and, commencing anesthesia via the second catheter.

Further illustratively according to this aspect, the method comprisesproviding a stimulating clip adjacent a proximal end of the first needlefor coupling the first needle to a peripheral nerve stimulator tofacilitate passing a current through the first needle and the patient'sbody to stimulate nerves in the area of the distal end of the firstneedle.

According to another aspect, a method for administering a peripheralnerve block to a patient comprises: penetrating the body of the patientwith a first needle sheathed within a first sheath having an open distalend through which a distal end of the first needle projects; advancingthe sheathed first needle to the general location of the nerve to beblocked; administering local anesthetic through the first needle;withdrawing the first needle; inserting a first catheter through thefirst sheath; connecting a proximal end of the first catheter to asource of local anesthetic; commencing anesthesia via the firstcatheter; introducing a second needle sheathed within a second sheathhaving an open distal end through which a distal end of the secondneedle projects into the body of the patient in a direction other thanthe direction in which the sheathed first needle was directed; advancingthe sheathed second needle to the general location of the distal end ofthe first catheter, withdrawing the second needle; inserting a secondcatheter through the second sheath; advancing the second catheter pastthe distal end of the first sheath; removing the first sheath; removingthe second sheath; connecting a proximal end of the second catheter to asource of local anesthetic; and, commencing anesthesia via the secondcatheter.

According to another aspect, a kit for administering a transversusabdominis plane (TAP) block to a patient comprises a needle, a sheathhaving an open distal end through which a distal end of the needle canproject, and a catheter of a size permitting the catheter to be advancedthrough the sheath until the catheter extends from a distal end of thesheath, the catheter having a proximal end permitting connecting aproximal end of the catheter to a source of local anesthetic.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the catheter to an infusionpump.

Further illustratively according to this aspect, the kit comprises asurgical drape having an opening through which a procedure may beperformed using the kit.

Further illustratively according to this aspect, the kit comprises anamount of a local anesthetic.

According to another aspect, a kit for administering a paravertebralblock (PVB) to a patient comprises a first needle, a first sheath havingan open distal end through which a distal end of the first needle canproject, and a first catheter of a size permitting the first catheter tobe advanced through the first sheath until the first catheter extendsfrom a distal end of the first sheath, the first catheter having aproximal end permitting connecting a proximal end of the first catheterto a source of local anesthetic.

Further illustratively according to this aspect, the kit comprises amarker for marking the skin of a patient.

Further illustratively according to this aspect, the kit comprises anamount of a local anesthetic.

Further illustratively according to this aspect, the kit comprises asurgical drape having an opening through which a procedure may beperformed using the kit.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the catheter to an infusionpump.

Further illustratively according to this aspect, the kit comprises asecond needle, a second sheath having an open distal end through which adistal end of the second needle can project, a second catheter of a sizepermitting the second catheter to be advanced through the second sheathuntil the second catheter extends from a distal end of the secondsheath, the second catheter having a proximal end permitting connectinga proximal end of the second catheter to a source of local anesthetic.

According to another aspect, a kit for administering an adductor canalblock (ACB) to a patient comprises a needle, a sheath having an opendistal end through which a distal end of the needle can project, and acatheter of a size permitting the catheter to be advanced through thesheath until the catheter extends from a distal end of the sheath, thecatheter having a proximal end permitting connecting a proximal end ofthe catheter to a source of local anesthetic.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the catheter to an infusionpump.

Further illustratively according to this aspect, the kit comprises asurgical drape having an opening through which a procedure may beperformed using the kit.

Further illustratively according to this aspect, the kit comprises anamount of a local anesthetic.

According to another aspect, a kit for administering a peripheral nerveblock to a patient comprises a first needle treated to render itssurface electrically non-conductive except adjacent its distal end, afirst sheath having an open distal end through which a distal end of thefirst needle can project, a first catheter of a size permitting thefirst catheter to be advanced through the first sheath until the firstcatheter extends from a distal end of the first sheath.

Further illustratively according to this aspect, the kit includes asecond needle, a second sheath having an open distal end through which adistal end of the second needle can project, and a second catheter of asize permitting the second catheter to be advanced through the secondsheath until the second catheter extends from a distal end of the secondsheath.

Further illustratively according to this aspect, the kit comprises astimulating clip adjacent a proximal end of the first needle forcoupling the first needle to a peripheral nerve stimulator to facilitatepassing a current through the first needle and the patient's body tostimulate nerves in the area of the distal end of the first needle.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the first catheter to aninfusion pump.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the second catheter to aninfusion pump.

Further illustratively according to this aspect, the kit comprises asurgical drape having an opening through which a procedure may beperformed using the kit.

Further illustratively according to this aspect, the kit comprises anamount of a local anesthetic.

According to another aspect, a kit for administering a peripheral nerveblock to a patient comprises a first needle, a first sheath having anopen distal end through which a distal end of the first needle canproject, a first catheter of a size permitting the first catheter to beadvanced through the first sheath until the first catheter extends froma distal end of the first sheath, a second needle, a second sheathhaving an open distal end through which a distal end of the secondneedle can project, and a second catheter of a size permitting thesecond catheter to be advanced through the second sheath until thesecond catheter extends from a distal end of the second sheath.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the first catheter to aninfusion pump.

Further illustratively according to this aspect, the kit comprises anadapter for coupling an external end of the second catheter to aninfusion pump.

Further illustratively according to this aspect, the kit comprises asurgical drape having an opening through which a procedure may beperformed using the kit.

Further illustratively according to this aspect, the kit comprises anamount of a local anesthetic.

According to another aspect, a kit for administering a peripheral nerveblock to a patient comprises an ultrasound opaque or semi-opaqueintroducer and an ultrasound opaque or semi-opaque catheter of a sizepermitting the catheter to be advanced through the introducer until thecatheter extends from a distal end of the introducer.

According to another aspect, a method for administering a peripheralnerve block to a patient comprises providing an ultrasound opaque orsemi-opaque introducer and providing an ultrasound opaque or semi-opaquecatheter of a size permitting the catheter to be advanced through theintroducer until the catheter extends from a distal end of theintroducer, and advancing the catheter through the introducer until thecatheter extends from a distal end of the introducer.

Illustratively according to this aspect, advancing the catheter throughthe introducer until the catheter extends from a distal end of theintroducer is performed under ultrasound guidance.

The invention may be understood by referring to the following detaileddescriptions and accompanying drawings. In the drawings:

FIG. 1 illustrates a 3½ inch (about 8.9 cm.) needle/sheath(introducer/sheath) assembled;

FIG. 2 illustrates the needle and sheath illustrated in FIG. 1disassembled;

FIG. 3 illustrates a needle/sheath assembly. The surface of the needleis electrically insulated down to within a centimeter or so of its tip,and a conductor is attached to its proximal end to permit attachment toa nerve stimulator;

FIG. 4 illustrates the assembly illustrated in FIG. 3 assembled into asheath;

FIG. 5 illustrates the assembly illustrated in FIG. 3 removed from thesheath;

FIG. 6 illustrates a needle and a catheter with the hub for connectingthe catheter to an infusion pump removed;

FIG. 7 illustrates a stimulating clip attached to the proximal end of awire which extends through a catheter;

FIG. 8 illustrates a prior art rib fracture kit and the inventiveintroducer/sheath (needle/sheath), in this case with a 6 inch (about15.2 cm.) needle and a 5 inch (about 12.7 cm.) needle; although theillustrated needle is a cutting type needle, a non-cutting (epiduralstyle) needle is contemplated;

FIG. 9 illustrates a sheath with the introducer (needle) removed and acatheter threaded into the proximal end of the sheath;

FIG. 10 illustrates a dorsal view of a rib cage illustrating the methodfor paravertebral block;

FIG. 11 illustrates the bulge in the peritoneum characteristic ofsuccessful administration of a laparascopic transversus abdominis planeblock;

FIG. 12 illustrates an ultrasonogram of the abdomen of a patient who hasreceived a laparascopic transversus abdominis plane block;

FIGS. 13-17 illustrate ultrasonograms of various phases in the progressof a fascia iliaca block;

FIG. 18 illustrates a partly cut away longitudinal sectional sideelevational diagram of apparatus constructed according to the invention;

FIG. 19 illustrates an assembled view of the apparatus illustrated inFIG. 18;

FIGS. 20-23 illustrate ultrasonograms of various phases in the progressof a supraclavicular block;

FIGS. 24-27 illustrate ultrasonograms of various phases in the progressof a paravertebral block;

FIGS. 28-39 illustrate various phases in the progress of asupraclavicular block.

The apparatus includes a sheath, an introducer/dilator, and a catheterwhich illustratively and desirably may have echogenic properties.

The sheath could be similar to I-flow's soaker sheath (I-Flow soakerkit, ref PM030, part 5001731) with its inherent echogenic properties, orusing material similar to I-Flow soaker sheath echogenic material in asheath construction similar to a Covidien Versaport™ bladeless lowprofile trocar, ref NB3SHFLP, 2 mm short. If the Covidien trocar-typesheath is used, the sheath needs to be a smaller diameter than theCovidien Versaport™ 2 mm short.

The introducer 30 could be an epidural needle similar to B. Braun (17gauge 4½ inch Tuohy needle, product code E11745T, ref 332181) or Becton,Dickinson Weiss needle (ref 405190, 18 gauge, 5 inch), and could beinsulated to permit stimulating nerve blocks or non-insulated forultrasound guided nerve blocks. Another option for the introducer 30would be a Veress needle such as Ethicon's pneumoneedle (150 mm refPN150). The Veress needle option provides a smoother transition than atypical Tuohy epidural needle's distal end. The sheath can be taperedmuch more closely to a Veress needle and avoid distal sheath shearingthan a Tuohy needle when penetrating a patient's skin. Another optionfor the introducer 30 would be similar to the obturator from a Covidienbladeless low profile trocar (refNB3SHFLP). This Covidien option wouldprovide a smooth, continuous, distal end with less penetrating qualitiesand be similar to many non-cutting introducer-trocars.

The apparatus 10 includes a sheath 12 having an open proximal end 16 andan open distal end 18. The sheath 12 is constructed from a flexibleultrasound echogenic material to permit location of sheath 12 in apatient's body 14 by ultrasound. The sidewall 20 of the sheath 12adjacent the open distal end 18 illustratively tapers 22 toward thedistal end 18 to aid the insertion into the patient 14. This sheath 12may be constructed with a side extension 26 near the proximal end 16.Such a side extension 26 may be useful to remove the sheath 12 from theintroducer/dilator 30 into the patient 14, as will be explained.

The apparatus 10 also includes a more rigid introducer/dilator 30 forintroducing the sheath 12 into the patient 14. The introducer/dilator 30is sized to be inserted into the sheath 12 to rigidify the sheath 12 forinsertion. The introducer/dilator 30 may include a tapered, for example,somewhat conical, tip 32 at its distal end 34. The base of the tip 32 issized and shaped to provide with the taper 22 of sheath 12 a fairlycontinuous, smooth surface to aid in insertion of the sheath12/introducer/dilator 30 assembly. Adjacent the point of the tip 32,passageways 36 may be provided through the introducer/dilator 30 for theintroduction of fluid, again, typically liquid, species through theintroducer/dilator 30 into the patient 14. A sealable or one way portmay be provided at the proximal end 40 of the introducer/dilator 30 forintroduction of such fluid species through a tube 41 and port 38 intothe passageway 42 between ends 34, 40 through the port 38, down thelength of the passageway 42 and out through the passageways 36 in thetip 32 into the body 14. Again, the introducer/dilator 30, particularlyits tip 32, should be ultrasound echogenic to permit location of tip 32in the body 14 by ultrasound.

The apparatus 10 further should have an ultrasound echogenic catheter,with characteristics and function similar to catheter 44. An example ofan echogenic catheter includes a catheter 44 with a soaker tip 46similar to the ON-Q® soaker catheter, part 4000950-1 (2.5 cm) availablefrom I-Flow Corporation, for inserting through the sheath 12 once theapparatus has been properly placed by ultrasound or direct vision. Ifthe sheath 12 is not a tearable type sheath, the catheter 44 does nothave the ON-Q® soaker catheter's injection port, because the sheath 12needs to be able to slide over the catheter 44 as the sheath 12 isremoved from the patient's body 14. The end of the catheter 44 not inthe body 14 then has a catheter adapter 48 snapped onto catheter part50, to permit the catheter 44 to be connected to an infusion pump 52.The catheter adapter 48 would work similarly to the snaplock adapteravailable from Arrow Corporation, epidural kit, reference SJ-05501.

It is envisioned that sheaths 12 and introducer/dilators 30 will come inlengths for infants, children and small women, adults, and obesepatients. It is envisioned that the needle lengths for non-stimulatingkits will likely be one inch (about 2.5 cm.), two inches (about 5 cm.),three and one-half inches (about 8.9 cm.) and five inches (about 12.7cm.). Kits with stimulating needles will have needles and sheaths inlengths of two inches (about 5 cm.) and three and one-half inches (about8.9 cm.). The catheters will come in lengths necessary or desirable forthe particular patient 14 and block with which they are to be used.

Typical procedures proceed as follows:

Percutaneous TAP Block

For both posterior and subcostal TAP blocks, the fascia under thepatient 14's internal oblique muscle is identified by ultrasound in theappropriate anatomy for either a posterior or subcostal TAP block. Theintroducer/dilator 30 is inserted into the proximal end 16 of sheath 12until tapered tip 32 projects from distal end 18 with the tip 32 andtaper 22 forming a smooth contour. A small incision may need to be madethrough the patient 14's skin to permit the sheath 12/introducer/dilator30 assembly to be pushed under ultrasound guidance to the plane betweenthe internal oblique and the transversus muscles. Two distinct “pops”are felt by the operator during this process, the first when the tip 32passes through the external oblique, and the second when the tip 32passes through the internal oblique. The tip 32 is placed in the fasciadirectly under the internal oblique to permit administration of localanesthetic through tubing 41 and out of openings 36, and then extensionof this pool of local anesthetic into an area in the transversusabdominis plane. The sheath 12/introducer/dilator 30 assembly isadvanced slightly in the fluid area. The introducer/dilator 30 is thenwithdrawn from sheath 12. The catheter 44 is then introduced into sheath12 and advanced an appropriate distance, as determined by the operator.The sheath 12 is then withdrawn, leaving the catheter 44 in place. Acatheter adapter 48 is attached to the external end 50 of the catheter44 and then connected to an infusion pump 52 such as the ON-Q®PainBuster® pump, filled with local anesthetic to permit the process tobegin.

LAP TAP

The surgeon performing a laparoscopic procedure can place a TAP blockunder direct vision at the end of an abdominal surgery. With the abdomenstill distended with carbon dioxide, the surgeon can view the areainside the peritoneum using (a) standard laparoscopic camera(s) andmonitor(s). Using the apparatus, the surgeon penetrates the patient 14'sabdomen in the area of a typical posterior or subcostal TAP. The surgeonunder direct camera vision penetrates through the skin, fat, externaloblique, internal oblique, transversus abdominis, and slides theapparatus 10 in a plane parallel to and just above the patient 14'speritoneum. The distal end 18 of sheath 12 and tapered tip 32 areoriented in the belly of the transversus abdominis muscle. Localanesthetic is given through tubing 41. If the surgeon has the apparatustoo deep, the surgeon will see the apparatus (with his/her laparoscopiccamera), and upon injection of local anesthetic will notice the surfaceof the peritoneum is ballooning. The surgeon should then simultaneouslywithdraw the apparatus slowly out of the patient 14 and inject localanesthetic until a bulge is seen. See FIG. 11. This bulging indicatesthe transversus abdominis rectus muscle is separating from the internaloblique. External confirmation of the LAP TAP area may be checked with asterile covered percutaneous ultrasound probe. The process then proceedsin a manner similar to the percutaneous TAP procedure described above.The introducer/dilator 30 is removed, the catheter 44 is advanced in thesheath 12, and the sheath 12 is removed leaving the catheter 44 in thebelly of the transversus abdominis muscle. The adapter 48 is attached tothe external and 50 of the catheter 44 and then connected to an infusionpump 52 to begin infusion.

FIG. 12 illustrates an ultrasonogram of the abdomen of a patient who hasreceived a laparascopic transversus abdominis plane block. The exterioroblique lies between the two lighter bands at the top of theultrasonogram. The upper band is skin and fat. The second band is thefascia between the exterior oblique and interior oblique. The interioroblique lies between the second lighter band from the top and the secondlighter band from the bottom. The second lighter band from the bottom isthe fascia between the interior oblique and the transversus abdominisrectus. The transversus abdominis rectus lies between the second lighterband from the bottom and the bottom brighter band. The bottom brighterband is the peritoneum. A pool of local anesthetic is the dark area tothe far right between the bottom two lighter bands.

Fascia Iliaca Block

The apparatus can also be used for placement of a continuous fasciailiaca block. The patient 14's appropriate area is located approximatelytwo fingers lateral from the femoral nerve and two fingers below theinguinal crease. A small skin incision may be required. Then the sheath12/introducer/dilator 30 assembly is manipulated to penetrate first thefascia lata and then the fascia iliaca. Local anesthetic is injectedthrough tubing 41, distending the iliaca muscle, thereby providing asafe passage for advancing the sheath 12 off the introducer/dilator 30.The sheath 12 is now in an appropriate area to cause an anterior lumbarplexus block. The catheter 44 is advanced into the sheath 12 anappropriate distance, the sheath 12 is removed, leaving the catheter 44.The adapter 48 is attached to the external end 50 of the catheter 44 andthen connected to an infusion pump 52 to begin infusion.

FIGS. 13-18 illustrate ultrasonograms and drawings of various phases inthe progress of a fascia iliaca block. In FIG. 13, the second lighterband from the top is the fascia lata. The third lighter band from thetop is the fascia iliaca. FIG. 14 illustrates how under ultrasoundguidance the introducer 30/sheath 12 (needle 30/sheath 12) is firstintroduced generally perpendicularly and then turned horizontally towardthe proximal thigh. FIG. 15 illustrates how under ultrasound guidancethe sheath 12 is advanced off the introducer 30 (needle 30). FIG. 16illustrates in the lower left an outline of the margins of the echogenicsheath 12. FIG. 17 illustrates near the top of the image the fascialata, just below the middle of the image the fascia iliaca and justbelow fascia iliac, near the bottom left of the image, the outline ofthe margins of the echogenic catheter 44.

Stimulating Needle/Non-Stimulating Catheter

Arrow International, Inc. (Teleflex Medical, PO Box 12600, ResearchTriangle Park, N.C. 27709) introduced an extremely popular stimulatingneedle/stimulating catheter (hereinafter sometimes the ACneedle/catheter) several years ago. Placement of continuous nerve blockswith the AC needle/catheter required considerable skill. The techniqueinvolved placing an epidural needle next to a peripheral nerve. Insidethe epidural needle is a stimulating catheter. This stimulating catheterconsisted of a small plastic tubing with a wound, “slinky-like,” metalcoil inside. This stimulating catheter was connected to a batterycapable of supplying a current. Specific muscle groups would bestimulated when the AC needle/catheter was near a peripheral nerve andthe appropriate electrical impulse was given, identifying the locationof the needle tip. This technique required knowledge of motor responsesby muscle groups and their respective anatomy. Problems with this ACneedle/catheter include the inner metal wire unwinding, the metal wirescraping nerves on removal, and expense to manufacture.

More recently, B. Braun Medical Inc., 824 Twelfth Avenue, Bethlehem, Pa.18018 introduced a stimulating needle/non-stimulating catheter(hereinafter sometimes the BB needle/catheter). The BB catheter has theappearance of lightweight monofilament fishing line. Advantages of theBB needle/catheter are the lack of metal in the catheter, which couldlead to a post-operative neuritis, and its case of use with ultrasound.Anesthesiology residents are now commonly trained with ultrasoundguidance for peripheral nerve blocks. Many practicing anesthesiologistsare working to learn ultrasound guided nerve blocks. There are, however,some shortcomings with the BB needle/catheter. The BB catheter isthreaded through a small, perforated opening in the BB needle. The BBcatheter can be difficult to advance through the BB needle because theBB catheter is very light in weight, flimsy and insubstantial. The endof the BB catheter tubing is attached by a catheter clip device which isnot of a particularly robust design. This catheter clip devicefrequently pulls off the very light weight catheter, becomingcontaminated in the process.

Both the AC needle/catheter and the BB needle/catheter are placed insidean epidural needle and advanced. Both of these techniques require muchdexterity on the part of the anesthesiologist.

According to the inventive technique, an epidural needle 30 is placedinside an introducer sheath 12. See FIG. 1. The surface of the needle 30is treated, for example, by coating with an electrically insulativematerial, down to within a few millimeters of its tip. This permits veryaccurate assessment of where the tip is when a current is applied, forexample, via the clip, to the needle 30. Using the sheath 12 reduces theskill required to place a peripheral nerve catheter. The catheter I haveselected is very robust and difficult to contaminate. A length ofextension tubing is attached to the epidural needle. See FIG. 2. Theneedle/sheath 12 is directed under ultrasound guidance to a targetperipheral nerve. A stimulating clip is attached to the epidural needleand the stimulator is used to confirm the placement performed byultrasound. See Figs. The needle is bolused with an appropriate localanesthetic, and the epidural needle is removed.

Illustratively, two or three different sizes of needles and sheaths 12will permit the anesthesiologist to perform the eight or nine commonnerve blocks. Initially, kits will be directed at all of the orthopedicperipheral nerve blocks. There would likely be four kits containingsimilar components. Differences will be, for example, in the lengths ofthe stimulating needles.

Generally, each kit will include an epidural needle, a first introducersheath 12, a second introducer sheath 12′, a continuous nerve catheter,a drape, extension tubing, and a stimulator clip and electricallyconductive wire or cable. Further details of illustrative components areas follow:

1) The stimulating needles are epidural needles that are insulated downto within a centimeter or so of their distal tips. Insulating the needlepermits electrical stimulation from only the distal end. It is currentlycontemplated that kits will be available with stimulating needles in thefollowing lengths: about 6.4 cm (about 2.5 inches); about 8.0 cm (about3.5 inches); about 11.4 cm (about 4.5 inches); and, about 14 cm (about5.5 inches). The stimulating needles have centimeter markings along thelength of the needle. An example of this type of needle comes from Arrowkit ref SJ-05501.

2) A suitable connecting cable to attach to a peripheral nervestimulator comes from Arrow kit ref AB-05060. The cable could comealready attached to the needle.

3) Two introducer sheaths 12, 12′ are currently contemplated. The sheath12 for the stimulating needle will be about two centimeters (about 0.8inch) shorter than the length of the stimulating needle. All of thestimulating needles will use an introducer sheath 12 similar to the onefrom I-Flow's (I-Flow Corporation, 20202 Windrow Drive, Lake Forest,Calif. 92630) soaker kit, ref. PM010, part#5001729. A second introducerneedle 30′ and sheath 12′ are required to locate the non-stimulatingcatheter away from the surgical field. This second introducer sheath 12′is similar to the one from I-Flow's soaker kit, ref. PM010,part#5001729. The introducer sheaths 12 and the non-stimulatingcatheters should be made as echogenic as materials and manufacturingmethods permit to facilitate location.

4) Two non-stimulating catheters are provided. One has an approximately2.5 cm (about one inch) distal soaker region similar to the one inI-Flow's soaker kit, PMO-30. Another similar catheter is the one fromArrow's flextip epidural kit, ref. SJ-05501.

5) Extension tubing should be similar to the tubing from Havel's(Havel's Incorporated 3726 Lonsdale Street Cincinnati, Ohio 45227)echogenic needle, EBA-21100. The extension tubing illustratively isabout 75 cm (about 30 inches) long.

6) An illustrative drape is Arrow drape product #CD-00001.Illustratively, the drape will have a rectangular, circular or ovalopening, although a rectangular opening is currently thought to providethe greatest flexibility.

In order to get the mechanism for introducing anesthetic out of thesurgical field, a second introducer needle 30′/sheath 12′ is placedthrough the original puncture site and directed away from the surgicalsite. A continuous nerve catheter is placed through the second sheath12′, into the original sheath 12 and advanced, for example, twocentimeters past the distal end 18 of the first sheath 12. Bothintroducer sheaths 12, 12′ are removed and a sealant, such as Dermabond®liquid skin adhesive, applied to both puncture sites. All extra tubingis secured in a sterile dressing. The nerve catheter is bolused by theanesthesiologist and confirmed by ultrasound.

FIG. 28 illustrates an area above the clavicle of a patient 14 with asurgical drape. FIG. 29 illustrates a first (tunnel) needle 30/sheath12. FIG. 30 illustrates the first (tunnel) needle 30 being insertedunder the patient 14's skin with the distal end 32 emerging (FIG. 31) ata predetermined marked site where a second needle 30′/sheath 12′ willsubsequently be inserted. In FIGS. 32-33, the first (tunnel) sheath 12is placed over the distal end of the tunnel needle 30 and both arewithdrawn, pulling the tunnel sheath 12 back through the tunnel made bythe tunnel needle 30. A first catheter 44 is advanced through the first(tunnel) sheath 12 until first catheter 44 reaches the opposite end ofthe tunnel. In FIG. 35, the first (tunnel) sheath 12 is then removed.The second needle 30′/sheath 12′ is then advanced into the same orificethat was created by the distal end of the tunnel needle 30/sheath 12with the aid of ultrasound visualization (FIGS. 36-37), and the nerveblock is performed as described above. Referring to FIG. 38, the secondneedle 30′ is removed, leaving the second sheath 12′ in the patient 14with its distal end 18 adjacent the nerve bundle to which the block hasjust been administered. The distal end 46 of the first catheter 44,which is protruding from the site where the block has been administered,is inserted into the proximal end 16 of the second sheath 12′ andadvanced down the second sheath 12′ to the location of the block withthe aid of ultrasound visualization as necessary. The second sheath 12′is then peeled back and removed. Referring to FIG. 39, the loop of thefirst catheter 44 extending from the site is then pulled back throughthe tunnel by pulling on the proximal end 50 of the first catheter 44.The first catheter 44 is thereby secured in place under the skin withits proximal access 48 away from the surgical field, ready to beconnected to a source 52 of local anesthetic.

Open TAP Block

Having described how anesthesiologists can place continuous TAP blockspercutaneously, and can place them through a laparascope, LAP TAP, Ihave also had success placing TAP catheters in open abdominalprocedures. A surgeon performing an open abdominal procedure can place aTAP block under direct vision. The surgeon can visualize the abdominalwall with a retractor and easily view the peritoneal cavity. Using theapparatus, the surgeon penetrates the patient 14's abdomen in an area ofa typical posterior or subcostal TAP block. The surgeon, under directvision, penetrates through the skin, fat, external oblique, internaloblique, and transversus abdominis muscles, and slides the apparatusalong a plane parallel to and just above the peritoneum. From this pointon, the process is similar to a LAP TAP. The distal end 18 of sheath 12and tapered tip 32 are oriented in the belly of the transversusabdominis muscle. Local anesthetic is administered through tubing 41. Ifthe surgeon has the apparatus too deep, the surgeon will see theapparatus penetrating the peritoneum, or if upon injection of localanesthetic, will notice the surface of the peritoneum is ballooning. Thesurgeon should then simultaneously withdraw the apparatus slowly out ofthe patient 14 and continue administering local anesthetic until a bulgeis seen. See FIG. 11. The bulging indicates the transversus abdominismuscle is separating from the internal oblique. The process thenproceeds in a manner similar to percutaneous TAP blocks, as describedabove. The introducer/dilator 30 is removed, the catheter 44 is advancedin the sheath 12, and the sheath 12 is removed leaving the catheter inthe belly of the transversus abdominis muscle. The adapter 48 isattached to the external end 50 of the catheter 44 and then connected toan infusion pump 52 to begin the infusion.

Paravertebral Block, or PVB

A PVB is a complex peripheral nerve block that involves nervesimmediately after they branch off from the spinal cord, and can be usedin breast surgery, thoracotomy, rib fractures and the like. A PVB hasmany advantages over traditional spinal/epidural blocks. PVB generallydoes not cause hypotension, urinary retention, or lower extremity motorblock. PVB is unlikely to cause neuraxial damage, epidural abscess, orhematomas. Pain control with PVB has been shown to be equal totraditional thoracic epidurals. Long term benefits for surgery patientshave been observed. Specifically, breast surgery patients have beenshown to experience less long term pain after mastectomy, and possibly areduction in breast cancer recurrence if they receive a pre-incisionalPVB. The most significant complication for anesthesiologists whenplacing PVB is pneumothorax. The main barrier for widespread use of PVBis the extremely limited number of anesthesiologists with training toperform this complex procedure. The described method and apparatus areintended to address these issues associated with PVB.

The parts required, and method for placement of the block are asfollows. A para-spinous soaker catheter is to be placed 1.25-2.54 cmlateral to the spinous process of a patient 14. The parts include a sixinch (about 15.2 cm), 17 gauge Tuohy epidural needle 30 (similar to, butslightly longer than BBraun product code E1745T, ref 332181), a 5⅞ inch(about 14.9 cm) tapered 22 para-spinous sheath 12 (similar to the sheathin I-Flow ref PM020 parts 5001730/101353400), a five inch (about 12.7cm) multi-orifice para-spinous soaker catheter 44, 46 (similar to thesoaker hose in I-Flow ref PM020 parts 5001730/101353400), intravenousextension tubing (such as Hospira 30 inch (about 76.2 cm) list no12656-28), and plastic drape (similar to Arrow clear fenestrated drapeproduct no. cd-00001). The epidural needle 30/para-spinous sheath 12assembly is sometimes referred to hereinafter as a para-spinousapparatus or PSA and may be referred to by the reference numbers 30, 12.

Method

The procedure can be performed in a lateral decubitus or prone position.In the description that follows, it will be assumed that the patient 14is in the prone position, and unilateral. The description is for aunilateral para-spinous catheter placement from T5 to C7 (vertebrae).The procedure can involve the entire thoracic vertebrae, thus requiringtwo catheters, one cephalad and one caudad, and may also be bilateral.

The patient 14 is placed in a prone position. C7 to T5 spinous processesare noted and external skin is marked. The patient 14 is prepped anddraped. A sterile ultrasound probe is placed transverse to the spine andthe depth of the transverse process and external intercostal muscle arenoted at each level to be blocked. Local anesthetic is placed at T5,approximately 1.25-2.54 cm lateral from the T5 spinous process. The PSA30, 12 is introduced at this site under the skin to a depth just abovethe external intercostal muscle. The PSA 30, 12 is then advancedcephalad, under ultrasound guidance at a depth just above the externalintercostal muscle of each vertebra, maintaining constant lateraldistance from the spinous process of about 1.25-2.54 cm. The PSA 30, 12advancement is aided with intermittent injection of local anesthetic.The PSA 30, 12 advancement is stopped when C7 skin marker is reached.The epidural needle 30 is removed from the PSA 30, 12, and then thepara-spinous multi-orifice catheter 44, 46 is advanced into thepara-spinous sheath 12. The para-spinous sheath 12 is removed leavingthe para-spinous catheter 44, 46 in proper position. The catheter 44, 46is covered with sterile dressings, bolused with local anesthetic, andconnected to an appropriate local anesthetic infusion device.

We have seen virtually pain free recovery after mastectomy, breastreconstruction, and axillary node dissection. This technique has alsorecently been used on a trauma patient who had 5-6 rib fractures after afall from a horse. The patient was 99 percent pain free after receivingthe described modified paravertebral block.

FIGS. 24-27 illustrate ultrasonograms of various phases in the progressof a paravertebral block. FIG. 24 illustrates the pleura of the lung(the white area at the bottom of FIG. 24), and just above it, theintercostal muscle. Entering from the right and just above theintercostal muscle, the introducer 30 (needle 30)/sheath 12 is visible.The target nerve bundle is to the left, below the center of FIG. 24. InFIG. 25, the introducer 30 (needle 30)/sheath 12 has been advanced andthe tip 32 of the needle 30 has reached the nerve bundle. In FIG. 26,the needle 30 has been withdrawn, leaving the sheath 12 ready to receivethe catheter 44. In FIG. 27, the catheter 44 has been advanced throughthe sheath 12 to adjacent the pleura (the lighter line at the bottom ofFIG. 27), the sheath 12 has been removed, and local anesthetic is beingadministered. The local anesthetic is the darker area between the tip 46of the catheter 44 and the pleura.

Other Blocks

Brachial plexus, sciatic, and saphenous nerve blocks are well documentedin regional anesthesia books, articles, and on the Internet. All ofthese blocks require advanced medical knowledge pertaining to humananatomy and ultrasound techniques. The common theme is as follows: atarget nerve plexus is visualized with an appropriate ultrasound unit;the patient 14 is prepped and draped; skin local anesthetic is given tothe appropriate site; the apparatus 10 is placed in the appropriate areanear the target nerve bundle; target site verification is performed byultrasound or ultrasound complemented with nerve stimulation (assuming astimulating Tuohy needle is the introducer/dilator 30); an appropriatelocal anesthetic is bolused through the introducer/dilator 30 and theintroducer/dilator 30 is then removed, leaving the sheath 12 in closeapproximation to the target nerve bundle; an echogenic catheter 44 isthen advanced to the distal end 18 of sheath 12 or until mild resistanceis encountered and the sheath 12 is then removed. Sterile dressings areapplied, an infusion pump 52 is connected to the catheter 44 andinfusion of the local anesthetic commences.

FIGS. 20-23 illustrate ultrasonograms of various phases in the progressof a supraclavicular block. In FIG. 20, the white lines which extendapproximately through the center of the figure mark the fascia of themiddle scalene. The dark ovals in the lower portion of the drawing,center and right illustrate nerve bundles and the subclavian artery.FIG. 21 illustrates the introducer 30 (needle 30)/sheath 12 enteringfrom the upper left toward the nerve bundle. FIG. 22 illustrates thesheath 12 after withdrawal of the introducer 30 (needle 30),introduction of the catheter 44 and introduction of an amount of localanesthetic. The local anesthetic is the dark area in the lower middle ofFIG. 22. FIG. 23 illustrates the catheter 44 in place in the pool oflocal anesthetic.

Adductor Canal Block or ACB

The adductor canal (subsartorial canal or Hunter's canal) is about 15 cmin length and is a narrow, fascial tunnel in the thigh. The adductorcanal is located deep to the middle third of the sartorius muscle. Theadductor canal provides an intermuscular passage through which thefemoral vessels pass to reach the popliteal fossa, where these vesselsbecome popliteal vessels. The adductor canal begins about 15 cm (about 6inches) inferior to the inguinal ligament, where the sartorius musclecrosses over the adductor longus muscle. The adductor canal ends at theadductor hiatus in the tendon of the adductor magnus muscle. Thesaphenous nerve and, in part, the obturator nerve traverse the adductorcanal. It is hypothesized that repeated administration of localanaesthetic into this aponeurotic space could provide sensory-only painmanagement for knee surgery, thus enhancing early ambulation afterprocedures like total knee replacement.

The adductor canal has been shown by MRI to be capable of holding about30 ml or so of fluid, for example, local anesthetic. Blocks of thesensory nerve passing through the adductor canal using 0.2 percentropivicaine have been achieved by administering 30 ml initial bolus and6 ml/hour for maintenance. The approximately 6 ml/hour for maintenancecan be reduced to the range of about 2-4 ml/hr after one day post op.Because the motor nerves are not anesthetized, there is no weakening ofthe quadriceps muscle. This reduces significantly the risk of injuryduring recuperation and promotes mobility, healing and recovery. Theprocedure requires ultrasound to place the soaker catheter accurately inthe adductor canal. The procedure also requires a constant infusion pumppost op to deliver the local anesthetic at initially 6 ml/hour or 2-4ml/hr after one day post op. The technique has been verified on severalpatients undergoing, for example, unilateral total knee arthroplasty(hereinafter sometimes uni TKA), anterior cruciate ligament (hereinaftersometimes ACL) repairs, and knee manipulations (Patients post-kneesurgery, such as total knee replacement, ACL repair, knee arthroscopy,and the like, may develop adhesions in the joint capsule. Theseadhesions can restrict full flexion and extension of the knee, resultingin decreased ability to walk correctly. Surgeons will occasionally treatthese patients with “frozen knee”-like symptoms by manipulating the kneeto full flexion and extension. This is a painful procedure and requiresa general anesthetic. This manipulation procedure may cause severe painafter the adhesions are broken, and lead to decreased ability to walk.Surgeons may request a “sensory only” post-op block, such as an adductorcanal, because it permits the patient to ambulate with minimal pain andcontinue physical therapy to avoid a recurrence of symptoms).Importantly, because this is a sensory nerve block only, and not a motornerve block, there is no risk of quadriceps weakness. It is believedthat most healthcare providers will prefer adductor canal blocks ratherthan femoral nerve blocks for these procedures.

Using an appropriate sterile technique, an adductor canal block can beaccomplished using a 4 inch (about 10.2 cm) B. Braun Tuohy needle 30,with a 3½ inch (about 8.9 cm) I-flow sheath 12 (for example, of the typepreviously identified) placed over the needle 30. The needle 30/sheath12 is connected to sterile IV tubing, attached to syringes of localanesthetic, and handed to an assistant. The physician, using ultrasound,identifies the patient 14's sartorius muscle approximately ⅓ of thedistance between the patient 14's inguinal ligament and patella. Thepatient 14's femoral artery can be observed under the roof of theadductor canal (the sartorius muscle), and the saphenous nerve lateralto the artery. The physician then guides the needle 30/sheath 12 to thebase of the sartorius muscle and injects a small amount (a fewmilliliters) of local anesthetic. This serves to identify the bottom ofthe sartorius fascia. Then the physician slightly advances the needle30/sheath 12 through this fascia and injects more local anesthetic(about 30 milliliters or so) under the sartorius muscle (roof ofadductor canal) lateral to the femoral artery. After 30 ml of localanesthetic is administered, the physician removes the needle 30, leavingthe sheath 12 in the patient 14's adductor canal. A catheter 44 such as,for example, the previously described I-flow catheter, is then insertedthrough the sheath 12, the sheath 12 is removed, and a sterile dressingis placed over the catheter 44 where the catheter 44 exits the patient14's skin. The proximal end 50 of the catheter 44 is connected 48 to aninfusion pump 52, and administration of local anesthetic via theinfusion pump 52 is commenced.

Thus, local anesthetic can be administered easily using a needle and aflexible sheath. A catheter is easily placed in a sheath. This permitseasy ultrasound visualization. This also admits of a sheath made from,for example, a clear plastic polymer that is barium coated or otherwisetreated to make it ultrasound opaque or semi-opaque. This would havegenerally the same ultrasound properties as the flexible sheath whilepermitting the sheath to be made somewhat stiffer. An epidural needle isagain the introducer. It is also possible to make the sheath andintroducer out of plastic polymers. Finally, it is possible to make theintroducer/sheath a one piece, ultrasound echogenic combination, forexample, out of ultrasound opaque or semi-opaque plastic polymers.

What is claimed is:
 1. A method for administering an adductor canalblock (ACB) to a patient, the method comprising: identifying thepatient's sartorius muscle, advancing a sheath and a needle sheathedwithin the sheath having an open distal end through which a distal endof the needle projects to the base of the sartorius muscle, injecting afirst amount of a local anesthetic into the sartorius muscle, whereinthe first amount of the local anesthetic is injected at the base of thesatorius muscle, identifying the bottom of the sartorius fascia,advancing the sheath and the sheathed needle through the sartoriusfascia, administering a second amount of a local anesthetic under thesartorius muscle, removing the needle, leaving the sheath in thepatient's adductor canal, inserting a catheter into the sheath andadvancing a distal end of the catheter through the sheath to theadductor canal, removing the sheath while leaving the catheter in place,connecting a proximal end of the catheter to a source of localanesthetic, and commencing anesthesia, wherein a third amount of localanesthetic is delivered into the patient's adductor canal.
 2. The methodof claim 1 wherein identifying the patient's sartorius muscle comprisesidentifying the patient's sartorius muscle using ultrasound.
 3. Themethod of claim 1 wherein connecting the proximal end of the catheter tothe source of local anesthetic, and commencing anesthesia comprisesconnecting the proximal end of the catheter to a constant infusion pumpto deliver the local anesthetic postoperatively.
 4. The method of claim1, wherein the catheter is a multi-orifice catheter and anesthesia isdelivered locally from the catheter while the catheter is left in place.